Fundz

Nur Exone Biologic reported raising $148,000 in an initial SEC Form D filing, from an offering of $243,000

PRIVATEAug 27, 2025$147.8K of $243.2K raised

Amount Raised

$148,000

$148,000 sold, per SEC Form D (first sale Aug 20, 2025)

Round Type

Venture

HaifaBiotechnology

Quick answer

NurExone Biologic raised $148,000 in a funding round, dated August 20, 2025. NurExone Biologic is based in Haifa, Haifa District, Israel.

How much did NurExone Biologic raise?
NurExone Biologic raised $148,000 in a funding round on August 20, 2025.
What does NurExone Biologic do?
NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System.
Where is NurExone Biologic based and how big is it?
NurExone Biologic is based in Haifa, Haifa District, Israel. Fundz records about 25 employees.
Who are the decision-makers at NurExone Biologic?
Fundz holds 2 contacts at NurExone Biologic, including the Head of Scientific Collaborations & External Partnerships. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as NurExone Biologic that raised within 45 days of this round, from Fundz verified event records.

  • Innventure raised $9.8M on October 3, 2025.
  • Motor City Dental Partners raised an undisclosed amount (Debt Financing) on October 2, 2025.
  • Leyden Labs raised $35M (Funding Round) on October 2, 2025.
  • OncoC4 raised $50M (Series B) on October 2, 2025.
  • Kihealth raised $5M (Seed) on October 2, 2025.
  • Cartography Biosciences raised $67M (Series B) on October 2, 2025.

Who to call at NurExone Biologic, and when

A new round usually means NurExone Biologic is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NurExone Biologic raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NurExone Biologic, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NurExone Biologic. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NurExone Biologic

Location

MINUS 1 ENTRY, GROUND FLOOR OF BLDG B

Haifa, Haifa District, Israel

About

NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System. The breakthrough exosome-based technology was proven in preclinical studies to have the potential to treat spinal cord injuries.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NurExone Biologic raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsLimor C., Head of Scientific Collaborations & Ext…See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for NurExone Biologic's next move

See what Strategic adds

NurExone Biologic raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.